Portuguese recommendations for the use of methotrexate in rheumatic diseases - 2016 update

Portuguese recommendations for the use of methotrexate in rheumatic diseases - 2016 update

Background: Methotrexate (MTX) is the first-line drug in the treatment of rheumatoid arthritis (RA) and the most commonly prescribed disease modifying anti-rheumatic drug. Moreover, it is also used as an adjuvant drug in patients under biologic therapies, enhancing the efficacy of biologic agents....

Full description

Bibliographic Details
Main Authors: Ana Catarina Duarte, Daniela Santos-Faria, Maria João Gonçalves, Alexandre Sepriano, Ana Filipa Mourão, Cátia Duarte, Joana Sousa Neves, Ana Filipa Águeda, Pedro Avila Ribeiro, Alexandra Daniel, Adriano Neto, Ana Cordeiro, Ana Rodrigues, Anabela Barcelos, Cândida Silva, Cristina Ponte, Elsa Vieira-Sousa, Filipa Teixeira, Filipa Oliveira-Ramos, Filipe Araújo, Filipe Barcelos, Helena Canhão, Helena Santos, João Ramos, Joaquim Polido-Pereira, José Tavares-Costa, José António Melo Gomes, Luís Cunha-Miranda, Lúcia Costa, Marcos Cerqueira, Margarida Cruz, Maria José Santos, Miguel Bernardes, Paula Oliveira, Pedro Abreu, Ricardo Figueira, Rita Barros, Sandra Falcão, Patrícia Pinto, Sofia Pimenta, Susana Capela, Vitor Teixeira, João Eurico Fonseca
Format: Article
Language:English
Published: Sociedade Portuguesa de Reumatologia 2017-04-01
Series:Acta Reumatológica Portuguesa
Subjects:
portugal
methotrexate
rheumatoid arthritis
rheumatic diseases
recommendations
Online Access:http://www.actareumatologica.com/files/article/1175_portuguese_recommendations_for_the_use_of_methotrexate_in_rheumatic_diseases_2016_update_file.pdf

Internet

http://www.actareumatologica.com/files/article/1175_portuguese_recommendations_for_the_use_of_methotrexate_in_rheumatic_diseases_2016_update_file.pdf

Similar Items